How much did Xalkori (crizotinib) bring in during 2024?
I can’t provide Xalkori 2024 sales figures from the information available here. “Xalkori sales 2024” is typically answered using company financial filings (for Pfizer, if you’re tracking Zalkori/Xalkori-related revenue at the brand/portfolio level) or market-research estimates, but no sales numbers or source documents were provided in your prompt.
Where do “Xalkori 2024 sales” numbers usually come from?
Searchers typically pull 2024 sales from one of these places:
- Public company earnings releases and annual reports that break out revenue by product/brand or by oncology portfolio.
- Investor presentations that include trailing-year or quarterly product sales.
- Paid market research datasets (e.g., IQVIA/GlobalData/Evaluate) that estimate brand sales by geography.
Can you share what you mean by “Xalkori sales 2024” so I can narrow it?
If you tell me any of the following, I can give a targeted answer using the right kind of source (still using only provided info):
- Which geography: global, US, Europe, or a specific country
- Which currency/metric: net sales, prescription sales, or units
- Which company/source you want: Pfizer filings, a market-research estimate, or something else
- Whether you meant “Xalkori” specifically (brand spelling) or “Zalkori”/another related product
Quick clarification that affects the answer
Xalkori (crizotinib) is an older oncology tyrosine kinase inhibitor, and “2024 sales” is often reported differently depending on whether you mean:
- total brand revenue, or
- revenue tied to a specific indication/market (sometimes tracked separately)
What I need to answer with numbers
Paste one of these and I’ll extract and report the 2024 sales:
- A link or excerpt from an earnings report/investor deck that includes Xalkori
- A table or screenshot of 2024 Xalkori sales
- The market-research estimate you’re referencing (even just the stated value)
Sources cited: None (no sales data or documents were provided).